Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.

Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels.

Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II).

Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II).

Effect of angiotensin II and an angiotensin II inhibitor on renin secretion in the dog.

The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans.

Angiotensin II monoclonal antibody: blood pressure effects in normotensive and spontaneously hypertensive rats.

Inhibition of human peptidyl dipeptidase (angiotensin I converting enzyme: kininase II) by human serum albumin and its fragments.

Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.

Localization of aristolochic acid in mouse kidney tissues by immunohistochemistry using an anti-AA-I and AA-II monoclonal antibody.

Intrarenal role of angiotensin II and [des-Asp1]angiotensin II.

The angiotensin II receptor and the actions of angiotensin II.

Tumor localization and biodistribution with radiolabeled monoclonal antibody against pancreatic cancer in tumor-bearing nude mice.

Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes.

Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

[Stability of some bradykinin analogues against kininase II (author's transl)].

Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor.

A comparison between the central effects of angiotensin II and its fragments, Des1-angiotensin II and Des1,2-angiotensin II.

Angiotensin II blockade with saralasin.

Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.

Sepsis and angiotensin II.

Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.

Mechanism of erythropoietin regulation by angiotensin II.

Release of vasopressin by angiotensin II.

Evaluation of (131)I-anti-angiotensin II type 1 receptor monoclonal antibody as a reporter for hepatocellular carcinoma.

Suggest Documents

Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels.

Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II).

Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II).

Effect of angiotensin II and an angiotensin II inhibitor on renin secretion in the dog.

The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans.

Angiotensin II monoclonal antibody: blood pressure effects in normotensive and spontaneously hypertensive rats.

Inhibition of human peptidyl dipeptidase (angiotensin I converting enzyme: kininase II) by human serum albumin and its fragments.

Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.

Localization of aristolochic acid in mouse kidney tissues by immunohistochemistry using an anti-AA-I and AA-II monoclonal antibody.

Intrarenal role of angiotensin II and [des-Asp1]angiotensin II.

The angiotensin II receptor and the actions of angiotensin II.

Tumor localization and biodistribution with radiolabeled monoclonal antibody against pancreatic cancer in tumor-bearing nude mice.

Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes.

Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

[Stability of some bradykinin analogues against kininase II (author's transl)].

Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor.

A comparison between the central effects of angiotensin II and its fragments, Des1-angiotensin II and Des1,2-angiotensin II.

Angiotensin II blockade with saralasin.

Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.

Sepsis and angiotensin II.

Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.

Mechanism of erythropoietin regulation by angiotensin II.

Release of vasopressin by angiotensin II.

Evaluation of (131)I-anti-angiotensin II type 1 receptor monoclonal antibody as a reporter for hepatocellular carcinoma.

Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.

Recommend Documents

Follow Us